Mariana Emerenciano

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Meet PRC2: A new player in T-cell acute lymphoblastic leukemia.

Meet PRC2: A new player in T-cell acute lymphoblastic leukemia.

Journal: Biochimica et biophysica acta. Reviews on cancer
Published: December 03, 2024

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.

Journal: Leukemia
Published: October 18, 2024

Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia.

Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia.

Journal: Scientific reports
Published: September 12, 2024

Characterisation of cells markers associated with IKZF1plus in BCP-ALL.

Characterisation of cells markers associated with IKZF1plus in BCP-ALL.

Journal: Translational oncology
Published: June 22, 2024

Frequency of polymorphisms in the IKZF1 and CDKN2A/2B genes and descriptive analysis in pediatric patients with acute lymphoblastic leukemia: a multicenter hospital-based prevalence study in Rio De Janeiro.

Frequency of polymorphisms in the IKZF1 and CDKN2A/2B genes and descriptive analysis in pediatric patients with acute lymphoblastic leukemia: a multicenter hospital-based prevalence study in Rio De Janeiro.

Journal: BMC cancer
Published: June 18, 2024

The recombinome of IKZF1 deletions in B-cell precursor ALL.

The recombinome of IKZF1 deletions in B-cell precursor ALL.

Journal: Leukemia
Published: March 15, 2023

IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line.

IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line.

Journal: Hematology, transfusion and cell therapy
Published: March 13, 2023

The KMT2A recombinome of acute leukemias in 2023.

The KMT2A recombinome of acute leukemias in 2023.

Journal: Leukemia
Published: February 08, 2023

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients.

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients.

Journal: Clinics (Sao Paulo, Brazil)
Published: January 13, 2023

The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.

The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.

Journal: International journal of molecular sciences
Published: December 16, 2022

Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.

Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.

Journal: Cancer genetics
Published: August 23, 2022

Outcome of adolescents and young adults with acute lymphoblastic leukemia in a single center in Brazil.

Outcome of adolescents and young adults with acute lymphoblastic leukemia in a single center in Brazil.

Journal: Hematology, transfusion and cell therapy
Published: February 17, 2022
Showing 1-12 of 50

Last Updated: 09/26/2026